Cell line · CVCL_B280
S2-013
Cancer cell line, Homo sapiens. Pancreatic ductal adenocarcinoma. 11 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. S2-013. Cell lines, record CVCL_B280. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_B280
On this page
Cell line
As Cellosaurus gives it.
- Name
- S2-013
- Accession
- CVCL_B280
- RRID
- RRID:CVCL_B280
- Synonyms
- SUIT2-013, S2013
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 73Y
- Category
- Cancer cell line
- Diseases
- Pancreatic ductal adenocarcinoma (NCIt C9120)
- Derived from
- Liver (metastatic)
- Parent
- SUIT-2 (CVCL_3172)
- Entry created
- 2012-06-06
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers11
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. | Adv Sci (Weinh) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells. | J Clin Invest | 2025 | Its Methods give the RRID and name the line | PubMed | |
| DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. | Elife | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. | Mol Cancer Ther | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells. | Cancer Discov | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia. | Curr Protoc Pharmacol | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer. | Sci Rep | 2018 | Its Methods give the RRID and name the line | PubMed | |
| Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines. | World J Gastroenterol | 2001 | Cellosaurus cites it | PubMed | |
| Correlation between CA19-9 production in vitro and histological grades of differentiation in vivo in clones isolated from a human pancreatic cancer cell line (SUIT-2). | J Gastroenterol Hepatol | 1992 | Cellosaurus cites it | PubMed |
1 to 10 of 11
See all 11 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | SUIT-2 | CVCL_3172 |
Source Cell lines
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| TKG | TKG 0709 |
Source Cellosaurus
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_B280
GET https://conductscience.org/api/cell-lines/v1/CVCL_B280/problems